| |
Article Title |
Author(s) |
Type |
Pages |
|
Diabetic Gastroparesis: Myth or Reality?
June 2012 (Vol. 10 | No. 6 | Pages 685-686)
We read with interest the article by Parkman et al in which they delineate the similarities and differences between diabetic and idiopathic gastroparesis. We would like to make some observations that ...
|
Vivek V. Gumaste
|
Correspondence
|
685-686
|
|
Reply
June 2012 (Vol. 10 | No. 6 | Pages 686-687)
We appreciate the comments from Dr Gumaste regarding our article, “Similarities and differences between diabetic and idiopathic gastroparesis,” and the opportunity to discuss his comments. Our series ...
|
Henry P. Parkman,
William L. Hasler,
Linda Nguyen,
Pankaj J. Pasricha,
William J. Snape,
Gianrico Farrugia,
Kenneth L. Koch,
Jorge Calles,
Thomas L. Abell,
Richard W. McCallum,
Katherine Yates,
Linda Lee,
Aynur Unalp–Arida,
James Tonascia,
Frank Hamilton
et al.
|
Correspondence
|
686-687
|
|
Immunoglobulin E Level and Its Significance in Patients With Primary Sclerosing Cholangitis
May 2012 (Vol. 10 | No. 5 | Page 563)
We read with great interest the article by Hirano et al. The authors analyzed data from 44 patients with primary sclerosing cholangitis (PSC) with serum levels of immunoglobulin (Ig)E and found that h...
|
Udayakumar Navaneethan,
Preethi G.K. Venkatesh,
Ravi P. Kiran
|
Correspondence
|
563-563
|
|
Reply
May 2012 (Vol. 10 | No. 5 | Pages 563-564)
We thank Nevaneethan et al for their interest in our study and giving us an opportunity to clarify some specific issues regarding ethnic differences in primary sclerosing cholangitis (PSC).
|
Kenji Hirano,
Suguru Mizuno,
Kazuhiko Koike
|
Correspondence
|
563-564
|
|
Gastric Acid Suppression and Clostridium difficile Infection: Is There a Causal Connection?
May 2012 (Vol. 10 | No. 5 | Page 564)
We read the article by Deshpande et al with great interest. The authors performed a meta-analysis to evaluate the association between proton pump inhibitor (PPI) therapy and the risk of Clostridium di...
|
Sahil Khanna,
Darrell S. Pardi
|
Correspondence
|
564-564
|
|
Reply
May 2012 (Vol. 10 | No. 5 | Page 564)
We recognize the concerns raised by Drs Khanna and Pardi in their letter. Regarding the omission of studies from our meta-analysis, the 2 specific papers discussed in their letter are indeed important...
|
Abhishek Deshpande,
Vinay Pasupuleti,
Adrian V. Hernandez,
Chaitanya Pant,
Thomas J. Sferra
et al.
|
Correspondence
|
564-564
|
|
Reply
April 2012 (Vol. 10 | No. 4 | Page 442)
Population health management involves “a set of interventions designed to maintain and improve people's health across the full continuum of care—from low-risk, healthy individuals to high-risk individ...
|
Spencer D. Dorn
|
Correspondence
|
442-442
|
|
Virus C Cure as a Motivation for Strong Lifestyle Change?
March 2012 (Vol. 10 | No. 3 | Page 326)
Data presented by Backus et al on mortality after treatment of patients with hepatitis C are very impressive; they show not only less hepatic mortality in case of cure of hepatitis C but also improvem...
|
Patrice Couzigou
|
Correspondence
|
326-326
|
|
Reply
March 2012 (Vol. 10 | No. 3 | Pages 326-327)
We agree with Dr Couzigou that our results indicate that sustained virologic response (SVR) is associated with the observed reduction in all-cause mortality but that the mechanism is not clear. We pos...
|
Lisa Backus
|
Correspondence
|
326-327
|
|
Certolizumab Pegol for Active Crohn's Disease
March 2012 (Vol. 10 | No. 3 | Page 327)
We read with interest the findings and conclusions of Sandborn et al regarding the efficacy of certolizumab pegol as induction therapy for patients with active Crohn's disease who are naïve to biologi...
|
Laura J. Blackmore,
Adam W. Harris
|
Correspondence
|
327-327
|
|
Reply
March 2012 (Vol. 10 | No. 3 | Pages 327-328)
We thank Drs Blackmore and Harris for their comments regarding our manuscript, in which we present a 6-week placebo-controlled trial evaluating the efficacy of certolizumab pegol (CIMZIA; UCB Pharma, ...
|
William J. Sandborn
|
Correspondence
|
327-328
|
|
Education by a Nurse Increases the Adherence to Therapy in Chronic Hepatitis C Patients
February 2012 (Vol. 10 | No. 2 | Page 203)
|
Seyed Moayed Alavian,
Seyed–Hossein Aalaei–Andabili
|
Correspondence
|
203-203
|
|
Reply
February 2012 (Vol. 10 | No. 2 | Page 203)
In their letter, Dr Alavian and colleagues commented on our article regarding the effects of education by a nurse on the adherence to therapy in chronic hepatitis C patients. They raised questions abo...
|
Dominique Larrey
|
Correspondence
|
203-203
|
|
Metabolic Syndrome and Alcohol Abuse: A Potential Hepatocarcinogenic Mix in Adolescents
February 2012 (Vol. 10 | No. 2 | Page 204)
|
Anna Alisi,
Valerio Nobili
|
Correspondence
|
204-204
|
|
Reply
February 2012 (Vol. 10 | No. 2 | Pages 204-205)
We thank Drs Alisi and Nobili for their comments on the metabolic syndrome and alcohol intake as important etiologies of liver disease in the pediatric population. The metabolic syndrome and alcohol i...
|
Ju Dong Yang,
Felicity T. Enders,
Terry M. Therneau,
Lucinda Orsini,
W. Ray Kim,
Lewis R. Roberts
et al.
|
Correspondence
|
204-205
|
|
Hepatocellular Carcinoma: Still in Search of Evidence-Based Care
February 2012 (Vol. 10 | No. 2 | Page 205)
|
Alain Braillon
|
Correspondence
|
205-205
|
|
Reply
February 2012 (Vol. 10 | No. 2 | Pages 205-206)
We thank Dr Braillon for his important comments on smoking as an etiology of hepatocellular carcinoma (HCC) and surveillance. We agree that most studies identify smoking as an independent risk factor ...
|
Ju Dong Yang,
William S. Harmsen,
Seth W. Slettedahl,
Felicity T. Enders,
Terry M. Therneau,
Lucinda Orsini,
W. Ray Kim,
Lewis R. Roberts
et al.
|
Correspondence
|
205-206
|
|
Variceal Bleeding in Cirrhotic Patients Is Associated With Adrenal Dysfunction: What Is the Evidence?
January 2012 (Vol. 10 | No. 1 | Page 95)
We read the article by Triantos and colleagues with great interest. The authors prospectively assessed adrenal function in 20 patients with variceal bleeding and 60 nonbleeding cirrhotic patients with...
|
Thierry Thevenot,
Jean–Paul Cervoni,
Vincent Di Martino
|
Correspondence
|
95-95
|
|
Reply
January 2012 (Vol. 10 | No. 1 | Page 95)
We appreciate the interest in our recent article by Thevenot et al and their comments on the role of corticosteroid-binding globulin (CBG), as the free-form cortisol is considered to be the biological...
|
Christos K. Triantos,
Maria Kalafateli,
Vasiliki Nikolopoulou,
Andrew K. Burroughs
|
Correspondence
|
95-95
|
